Tp. Zucker et al., TOLERANCE DEVELOPMENT TO ANTIMITOGENIC ACTIONS OF PROSTACYCLIN BUT NOT OF PROSTAGLANDIN E-1 IN CORONARY-ARTERY SMOOTH-MUSCLE CELLS, European journal of pharmacology, 345(2), 1998, pp. 213-220
This study compares the antimitogenic effects of iloprost and prostagl
andin E-1 on platelet-derived growth factor-BE stimulated DNA synthesi
s ([H-3]thymidine incorporation) in bovine coronary artery smooth musc
le cells. When added 20-24 h after stimulation with platelet-derived g
rowth factor-BB (20 ng/ml), both iloprost and prostaglandin E-1, conce
ntration-dependently (IC50 3-5 nM) inhibited DNA synthesis. However, w
hen added together with the growth factor (0-24 h), the inhibition of
DNA synthesis by iloprost was markedly attenuated, indicating toleranc
e development. In contrast, no tolerance to antimitogenic effects of p
rostaglandin E-1 or forskolin were observed. When added to iloprost-to
lerant cells, both prostaglandin E-1 and forskolin, still inhibited DN
A synthesis. There was no evidence for transcriptional down-regulation
of prostacyclin receptor gene by iloprost. The data demonstrate a tol
erance development to antimitogenic actions of prostacyclin but not of
prostaglandin E-1 and suggest that the receptors. mediating the antip
roliferative actions of these prostaglandins, may be different. (C) 19
98 Elsevier Science B.V.